Health Care & Life Sciences » Biotechnology | NanoString Technologies Inc.

NanoString Technologies Inc.

NanoString Technologies Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
29.79 M
Public Float
21.54 M
NanoString Technologies Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.74
Market Cap
$1.02 B
Shares Outstanding
35.05 M
Public Float
28.54 M

Profile

Address
530 Fairview Avenue North
Seattle Washington 98109
United States
Employees -
Website http://www.nanostring.com
Updated 07/08/2019
NanoString Technologies, Inc. engages in the provision of life science tools for translational research and molecular diagnostic products. It offers analysis solutions, gene expression panels, protein assays, DNA Assaya, miRNA assays, vantage 3D assays, custom solutions, sample prep and nCounter consumables, and nDesign gateway. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

Financials

View All

Robert Bradley Gray
President, Chief Executive Officer & Director
William D. Young
Chairman